Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-21-046362

Chief Business Officer sold 7,500 shares at an average $23.92 ($179,419)

  • Chief Business Officer acquired 7,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Beaurang Pierre · Chief Business Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2021-07-12 Exercise or conversion : show line 1 in the form +7,500 $1.11 $8,325 11,830 D
2021-07-12 Sale : show line 2 in the form −7,100 $23.88 $169,527 4,730 D
2021-07-12 Sale : show line 3 in the form −400 $24.73 $9,892 4,330 D
Open-market sales · 7,500 sh · avg $23.92 · $179,419

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-07-12 Exercise or conversion : show line 4 in the form Employee Stock Option (right to buy) −7,500 $1.11 2027-02-01 7,500 14,062 D
Loading xslF345X03/doc4.xml…